Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Share-based Compensation: 2019-2024

Historic Share-based Compensation for Beauty Health (SKIN) over the last 6 years, with Dec 2024 value amounting to $26.7 million.

  • Beauty Health's Share-based Compensation fell 68.17% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.1 million, marking a year-over-year decrease of 26.03%. This contributed to the annual value of $26.7 million for FY2024, which is 18.42% up from last year.
  • Per Beauty Health's latest filing, its Share-based Compensation stood at $26.7 million for FY2024, which was up 18.42% from $22.5 million recorded in FY2023.
  • In the past 5 years, Beauty Health's Share-based Compensation ranged from a high of $28.5 million in FY2022 and a low of $363,000 during FY2020.
  • Over the past 3 years, Beauty Health's median Share-based Compensation value was $26.7 million (recorded in 2024), while the average stood at $25.9 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first soared by 3,320.94% in 2021, then declined by 20.88% in 2023.
  • Yearly analysis of 5 years shows Beauty Health's Share-based Compensation stood at $363,000 in 2020, then surged by 3,320.94% to $12.4 million in 2021, then skyrocketed by 129.47% to $28.5 million in 2022, then fell by 20.88% to $22.5 million in 2023, then increased by 18.42% to $26.7 million in 2024.